“Monkey Dust” is a street term associated with synthetic cathinones such as MDPV and MDPHP. These laboratory-made stimulants may contribute to compulsive redosing, prolonged wakefulness, severe anxiety, paranoia, hallucinations, psychosis, and potentially dangerous physical effects.
U.S. drug-monitoring researchers renewed attention to Monkey Dust in 2026. Current evidence does not establish a widespread Monkey Dust outbreak in Tennessee or Kentucky, but the trend is worth understanding as synthetic stimulants and street-drug terminology continue to evolve.
A person does not need to know the exact chemical name of an illicit stimulant before asking for help. Tulip Hill Healthcare can help review current substance use, withdrawal concerns, mental-health symptoms, location preferences, and level-of-care needs.
Monkey Dust is a street name rather than one standardized chemical product.
The term has historically been associated most closely with MDPV, or methylenedioxypyrovalerone. More recent research has also used the name for MDPHP and related pyrovalerone-type synthetic cathinones.
Synthetic cathinones are laboratory-made stimulants chemically related to cathinone, a naturally occurring stimulant found in the khat plant. They belong to the broader group of drugs often called bath salts.
A product sold as Monkey Dust may contain MDPV, MDPHP, another synthetic cathinone, or additional substances. Clinicians therefore consider symptoms and the complete pattern of use rather than relying only on a street name.
MDPV is not a newly discovered drug. It gained substantial attention during the earlier U.S. wave of synthetic cathinones commonly referred to as bath salts.
The newer development is renewed surveillance.
In 2026, the National Drug Early Warning System began more focused monitoring of MDPV and Monkey Dust after an early-warning alert and renewed discussion involving compulsive redosing, prolonged stimulant use, psychosis, and dependence.
Online drug discussion is not proof that a substance is widespread. Its value is as an early-warning signal that may identify terminology and reported experiences worth investigating through toxicology, poison-center, law-enforcement, and public-health data.
Current evidence does not justify describing Tennessee or Kentucky as experiencing a widespread Monkey Dust epidemic. The appropriate response is awareness and continued monitoring rather than sensationalism.
Current evidence does not establish widespread Monkey Dust use in Tennessee.
Tennessee does, however, maintain forensic procedures for the broader drug class involved. The Tennessee Bureau of Investigation has procedures for identifying bath salts, synthetic cathinones, and related analogues.
Kentucky should be approached with the same caution. A national emerging-drug signal should not automatically be described as a confirmed local outbreak.
For families and treatment providers, the practical focus should remain on recognizing dangerous stimulant effects, compulsive use, psychiatric symptoms, and polysubstance exposure regardless of the street name being used.
Both are stimulants and can increase energy, alertness, heart rate, blood pressure, and wakefulness. Heavy use of either may contribute to insomnia, severe anxiety, paranoia, hallucinations, agitation, and psychosis.
They are chemically and pharmacologically different substances.
Cocaine and MDPV both affect dopamine signaling, but they have different pharmacological characteristics. Calling Monkey Dust “strong cocaine” oversimplifies differences in potency, duration, repeated-use patterns, and illicit product composition.
Flakka has most commonly referred to alpha-PVP. Monkey Dust has historically been associated more closely with MDPV and MDPHP. Both belong to the synthetic-cathinone family but should not be treated as interchangeable chemical names.
Bath salts is an umbrella term used for many synthetic cathinones. Monkey Dust generally refers to a smaller group of pyrovalerone-type stimulants within that larger drug category.
Synthetic cathinones can produce significant stimulant effects.
Someone may initially feel unusually energetic, awake, confident, talkative, or alert. Appetite may decline, and sleep may become difficult.
As repeated use continues, the effects can become more concerning.
Stimulant exposure can increase anxiety, physical tension, panic, suspiciousness, rapid heart rate, and blood pressure. With heavy use, paranoia may become severe.
Repeated stimulant use may keep someone awake for prolonged periods. As sleep deprivation worsens, concentration, emotional regulation, judgment, and perception may deteriorate.
Heavy synthetic-cathinone use may contribute to hallucinations, delusional beliefs, confusion, extreme suspiciousness, and stimulant-induced psychosis.
One of the recurring concerns associated with some pyrovalerone-type cathinones is repeated dosing.
Someone may intend to use the stimulant once. As the desired effects fade, another dose follows. Then another.
The pattern can continue for many hours.
Sleep disappears, eating and drinking may decline, anxiety can increase, and judgment may deteriorate.
Someone can become physically exhausted while still feeling psychologically driven to continue using. When use finally stops, extreme fatigue, depressed mood, anxiety, irritability, poor concentration, and strong cravings may follow.
Severe synthetic-cathinone toxicity can become medically dangerous.
Possible complications include seizures, extreme agitation, dangerously elevated body temperature, severe hypertension, rapid or abnormal heart rhythms, chest pain, dehydration, muscle breakdown, kidney injury, psychosis, and loss of consciousness.
Seizures, severe chest pain, extreme overheating, loss of consciousness, breathing problems, dangerous agitation, or severe confusion require emergency medical attention.
Naloxone reverses opioid effects. It does not reverse synthetic-stimulant toxicity.
If opioid exposure is possible and someone is unconscious or breathing abnormally, administer naloxone and call 911. Illicit substances may contain drugs someone did not intend to take.
Synthetic stimulants may be used with alcohol, benzodiazepines, methamphetamine, cocaine, opioids, prescription medications, or other substances.
This can substantially change the medical and withdrawal picture.
Alcohol or benzodiazepine dependence may create withdrawal risks different from stimulant withdrawal. Opioid exposure may introduce respiratory depression and overdose risk. Treatment planning should consider everything the person has been using rather than one reported street name.
Synthetic cathinones can produce compulsive patterns of use.
Warning signs may include repeated redosing, using more than intended, prolonged binges, strong cravings, unsuccessful attempts to stop, neglecting responsibilities, and continuing despite psychiatric or physical consequences.
Someone does not need to know exactly which synthetic cathinone they used before recognizing that stimulant use has become difficult to control.
Talk With AdmissionsNot everyone stopping a synthetic stimulant requires inpatient medical detox.
Synthetic stimulant withdrawal generally differs from severe alcohol or benzodiazepine withdrawal, but the post-use period can still involve significant psychiatric and medical concerns.
Severe psychosis, seizures, cardiovascular symptoms, suicidal thinking, extreme agitation, or another acute medical concern may require hospital-level stabilization first.
Once medically and psychiatrically stable, someone may benefit from residential treatment, PHP, IOP, outpatient treatment, dual-diagnosis services, or another level of structured care based on clinical need.
Tulip Hill Healthcare connects individuals and families with addiction and mental-health treatment through a network of facilities offering different levels of care.
Depending on clinical need and location, treatment may include medical detox, residential treatment, partial hospitalization, intensive outpatient treatment, outpatient care, dual-diagnosis treatment, therapy, and continuing-care planning.
Live Again Detox in Nashville and Tennessee Detox Center in La Vergne provide detox and residential treatment. Tulip Hill Recovery in Murfreesboro provides structured addiction and mental-health treatment including PHP and IOP for appropriate clients.
Explore Tennessee Locations
The Tulip Hill Healthcare network also includes Serenity Ranch Recovery, Lexington Addiction Center, Louisville Addiction Center, and Kentucky Recovery Center, with available levels of care varying by location.
View All LocationsThere is currently no medication approved specifically for Monkey Dust addiction.
Treatment may focus on behavioral therapy, individual counseling, group therapy, psychiatric care when appropriate, sleep stabilization, coping skills, relapse prevention, family involvement, and continued recovery planning.
Someone recovering from prolonged stimulant use may also need support for depression, anxiety, trauma, insomnia, psychosis, bipolar disorder, or other mental-health concerns. Integrated treatment can address both substance use and mental health when clinically appropriate.
Recovery may involve rebuilding healthy sleep, strengthening coping skills, identifying triggers, repairing relationships, continuing therapy, and creating a plan for responding to cravings or early warning signs.
This article is educational and does not replace an individualized medical or psychiatric assessment.
Monkey Dust is a street term most commonly associated with synthetic cathinones such as MDPV and MDPHP.
Current evidence does not establish widespread Monkey Dust use in Tennessee. Tennessee forensic laboratories do maintain procedures for identifying synthetic cathinones and related analogues.
Current evidence does not establish a widespread Monkey Dust outbreak in Kentucky. Emerging national trends should not automatically be treated as confirmed local prevalence.
Monkey Dust generally refers to particular synthetic cathinones within the broader group commonly called bath salts.
No. Flakka has most commonly referred to alpha-PVP, while Monkey Dust has more often been associated with MDPV and MDPHP.
Yes. Synthetic cathinones can be associated with severe paranoia, hallucinations, confusion, and stimulant-induced psychosis.
Seizures can occur during severe synthetic-cathinone toxicity and require emergency medical care.
Naloxone does not reverse stimulant toxicity. It should still be administered if opioid exposure is suspected.
Synthetic cathinones can produce strong cravings, repeated redosing, prolonged binges, and loss of control over use.
No. Treatment needs depend on medical stability, psychiatric symptoms, other substances, withdrawal risks, and overall clinical needs.
Yes. Integrated treatment can address substance use alongside co-occurring mental-health concerns when clinically appropriate.
The appropriate setting depends on current substance use, withdrawal risk, medical and psychiatric stability, previous treatment, recovery environment, and level-of-care needs. Admissions can help compare available facilities and treatment settings.
If stimulant use has become difficult to control, repeated binges are occurring, psychiatric symptoms are worsening, or several substances are involved, Tulip Hill Healthcare can help identify an appropriate treatment setting within the network.
Dr. Vahid Osman is a Board-Certified Psychiatrist and Addictionologist who has extensive experience in skillfully treating patients with mental illness, chemical dependency and developmental disorders. Dr. Osman has trained in Psychiatry in France and in Austin, Texas. Read more.
Joshua Sprung serves as a Clinical Reviewer at Tennessee Detox Center, bringing a wealth of expertise to ensure exceptional patient care. Read More
UMR. (n.d.). About UMR. UMR. https://www.umr.com/about-umr
HealthCare.gov. (n.d.). Mental health & substance use disorder coverage. HealthCare.gov. https://www.healthcare.gov/coverage/mental-health-substance-abuse-coverage/
MR. (n.d.). Member portal. UMR. https://www.umr.com/member
The Joint Commission – The Gold Seal of Approval® signifies that Tulip Hill Healthcare meets or exceeds rigorous national standards for patient care, safety, and quality.
LegitScript Certified – Confirms compliance with laws and standards for transparency and ethical marketing in addiction treatment.
BBB Accredited – Demonstrates Tulip Hill Healthcare’s commitment to ethical business practices and community trust.
Psychology Today Verified – Indicates a verified listing on Psychology Today for trustworthy treatment services.
HIPAA Compliant – Ensures patient information is protected under federal privacy regulations.
ASAM Member – Reflects a commitment to science-based addiction treatment as a member of the American Society of Addiction Medicine.
Nashville Chamber of Commerce Member – Signifies active engagement in community and regional development efforts.
CARF Accredited – Demonstrates that Tulip Hill Healthcare meets internationally recognized standards for quality, accountability, and service excellence in behavioral health care.
Hear directly from those who have walked the path to recovery. Our patients’ stories highlight the compassionate care, effective programs, and life-changing support they’ve experienced. Let their journeys inspire you as you take your first steps toward healing.
